1. Home
  2. ARBE vs CRBP Comparison

ARBE vs CRBP Comparison

Compare ARBE & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbe Robotics Ltd.

ARBE

Arbe Robotics Ltd.

HOLD

Current Price

$0.79

Market Cap

135.0M

Sector

Technology

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$8.14

Market Cap

134.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARBE
CRBP
Founded
2015
2009
Country
Israel
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
135.0M
134.8M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
ARBE
CRBP
Price
$0.79
$8.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
$2.38
$46.17
AVG Volume (30 Days)
2.5M
157.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
64.31
EPS
N/A
N/A
Revenue
N/A
$4,822,272.00
Revenue This Year
$743.57
N/A
Revenue Next Year
$326.31
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
97.62
52 Week Low
$0.76
$4.64
52 Week High
$2.88
$20.56

Technical Indicators

Market Signals
Indicator
ARBE
CRBP
Relative Strength Index (RSI) 32.21 51.67
Support Level N/A $7.77
Resistance Level $1.46 $8.50
Average True Range (ATR) 0.08 0.49
MACD -0.02 0.09
Stochastic Oscillator 7.25 65.13

Price Performance

Historical Comparison
ARBE
CRBP

About ARBE Arbe Robotics Ltd.

Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: